This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Bisgaier Charles PhD | 41,481 | 48,000 |
| Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | 31,008 | 0 |
| Lowenschuss David | 26,874 | 0 |
| Sooch Mina | 23,124 | 0 |
| SASSINE ANDY | 4,542 | 10,800 |
| Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | 2,729 | 0 |
| LICHTINGER PEDRO | 1,994 | 2,000 |
| Reno Seth | 609 | 0 |
| MATHIESEN JEFFREY S | 264 | 0 |
| KOUSKY KENNETH W | 33 | 10,800 |
| Versavel Mark | 0 | 45,724 |
| Sooch Mina Held by the Arvinder S. Sooch Trust | 0 | 0 |
| Oh Jeong Gyun Held by JK BioPharma Solutions, Inc. | 0 | 0 |
| Jeong Tae Heum | 0 | 0 |
| DONG-A ST CO., LTD | 0 | 0 |
| Kim Na Yeon Held by The E&Healthcare Investment Fund No. 7 | 0 | 0 |
| Bakshi Akash | 0 | 0 |
| KOUSKY KENNETH W Held by BWA Gemphire Investment Group II, LLC | 0 | 0 |
| Bisgaier Charles PhD Held by The Charles L. Bisgaier Trust | 0 | 0 |
| Kang Sun Dae | 0 | 0 |
| E&Healthcare Investment Fund No.7 Held by The E&Healthcare Investment Fund No. 7 | 0 | 0 |
| JK BioPharma Solutions, Inc | 0 | 0 |
| Kim Na Yeon Held by The E&Healthcare Investment Fund No. 6 | 0 | 0 |
| E&Investment, Inc. Held by The E&Healthcare Investment Fund II | 0 | 0 |
| GROVES JASON L | 0 | 0 |
| GOLDMAN SACHS & CO | 0 | 0 |
| Price Ben Gil | 0 | 0 |
| 0 | 0 | |
| Golden Lee Scott | 0 | 0 |
| Swirsky Douglas J | 0 | 0 |
| Hawryluk P. Kent Held by the P. Kent Hawryluk Trust | 0 | 0 |
| KOVEN ANDREW I | 0 | 0 |
| Kim Na Yeon Held by The E&Healthcare Investment Fund II | 0 | 0 |
| E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 6 | 0 | 0 |
| Oh Jeong Gyun Held by spouse. | 0 | 0 |
| Hawryluk P. Kent | 0 | 10,800 |
| Bisgaier Charles PhD Held by Bisgaier Family, LLC | 0 | 0 |
| Kim Na Yeon | 0 | 0 |
| Oh Jeong Gyun | 0 | 0 |
| Gullans Steven R. Ph.D. | 0 | 60,000 |
| E&Healthcare Investment Fund No.7 Held by The E&Healthcare Investment Fund No. 6 | 0 | 0 |
| Salsbury Michael | 0 | 0 |
| Kim Na Yeon Held by E&Investment Inc. | 0 | 0 |
| E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 7 | 0 | 0 |
| Kim Hyung Heon | 0 | 0 |
| Glickman Mark A | 0 | 0 |
| Oniciu Carmen Daniela | 0 | 0 |
| E&Healthcare Investment Fund No.7 Held by The E&Healthcare Investment Fund II | 0 | 0 |
| STRICKLAND D GORDON | 0 | 0 |
| KOUSKY KENNETH W Held by BWA Gemphire Investment Group, LLC | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|